GS
follow link to MSigDB
GS DETAILSSIZEESNESNOM p-valFDR q-valFWER p-valRANK AT MAXLEADING EDGE
1FISCHER_DREAM_TARGETSDetails ...36-0.53-1.610.0001.0000.68188tags=39%, list=14%, signal=43%
2CHICAS_RB1_TARGETS_CONFLUENTDetails ...27-0.56-1.510.0000.9160.84652tags=22%, list=8%, signal=23%
3KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UPDetails ...55-0.34-1.510.0000.6650.84641tags=16%, list=7%, signal=16%
4REACTOME_CELL_CYCLEDetails ...25-0.45-1.470.0000.6370.84625tags=16%, list=4%, signal=16%
5MARSON_BOUND_BY_E2F4_UNSTIMULATEDDetails ...31-0.46-1.460.0000.5500.846141tags=52%, list=23%, signal=64%
6REACTOME_CELL_CYCLE_MITOTICDetails ...21-0.42-1.460.0000.5040.84617tags=14%, list=3%, signal=14%
7GARY_CD5_TARGETS_DNDetails ...21-0.49-1.450.0000.4610.84622tags=19%, list=4%, signal=19%
8SENESE_HDAC3_TARGETS_DNDetails ...17-0.52-1.430.0000.4690.84683tags=24%, list=13%, signal=26%
9JOHNSTONE_PARVB_TARGETS_3_DNDetails ...44-0.37-1.370.0000.5321.00088tags=27%, list=14%, signal=30%
10PUJANA_BRCA2_PCC_NETWORKDetails ...15-0.57-1.360.0000.5241.00036tags=33%, list=6%, signal=35%
11NUYTTEN_EZH2_TARGETS_DNDetails ...29-0.46-1.360.0000.4991.000129tags=41%, list=21%, signal=50%
12WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8DDetails ...17-0.37-1.350.0000.4951.00029tags=18%, list=5%, signal=18%
13CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DNDetails ...27-0.55-1.310.0000.5261.00052tags=22%, list=8%, signal=23%
14PHONG_TNF_RESPONSE_NOT_VIA_P38Details ...27-0.33-1.290.0000.5311.00015tags=15%, list=2%, signal=15%
15VECCHI_GASTRIC_CANCER_EARLY_UPDetails ...18-0.32-1.260.0000.5551.0007tags=11%, list=1%, signal=11%
16OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UPDetails ...20-0.39-1.260.0000.5371.000132tags=35%, list=21%, signal=43%
17DAZARD_RESPONSE_TO_UV_NHEK_DNDetails ...19-0.46-1.260.0000.5181.00017tags=21%, list=3%, signal=21%
18KIM_WT1_TARGETS_DNDetails ...24-0.47-1.250.0000.5251.00022tags=17%, list=4%, signal=17%
19LIAO_METASTASISDetails ...22-0.39-1.240.0000.5081.00055tags=23%, list=9%, signal=24%
20PATIL_LIVER_CANCERDetails ...20-0.41-1.240.0000.5121.00017tags=15%, list=3%, signal=15%
21REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE16-0.39-1.210.0000.5451.000232tags=63%, list=38%, signal=98%
22GRYDER_PAX3FOXO1_TOP_ENHANCERS34-0.27-1.210.3170.5411.00025tags=6%, list=4%, signal=6%
23REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION16-0.41-1.200.0000.5301.000166tags=50%, list=27%, signal=67%
24CAIRO_HEPATOBLASTOMA_CLASSES_UP20-0.39-1.150.0000.6011.00038tags=15%, list=6%, signal=15%
25REACTOME_VESICLE_MEDIATED_TRANSPORT28-0.30-1.110.0000.6441.00050tags=11%, list=8%, signal=11%
26PUJANA_CHEK2_PCC_NETWORK21-0.44-1.100.3520.6451.00036tags=19%, list=6%, signal=20%
27TIEN_INTESTINE_PROBIOTICS_24HR_UP28-0.34-1.090.0000.6371.000134tags=29%, list=22%, signal=35%
28UDAYAKUMAR_MED1_TARGETS_DN16-0.37-1.080.0000.6321.00015tags=19%, list=2%, signal=19%
29CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_128-0.34-1.040.3370.7161.00072tags=29%, list=12%, signal=31%
30DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN24-0.32-1.030.3530.7141.00017tags=13%, list=3%, signal=12%
31SMID_BREAST_CANCER_BASAL_UP29-0.36-1.030.0000.7021.00092tags=28%, list=15%, signal=31%
32FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN22-0.29-0.960.3520.8211.00024tags=14%, list=4%, signal=14%
33GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN41-0.27-0.930.6790.8401.000147tags=34%, list=24%, signal=42%
34GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN86-0.18-0.920.6790.8541.000152tags=29%, list=25%, signal=33%
35ONKEN_UVEAL_MELANOMA_DN23-0.18-0.900.3170.8571.000108tags=17%, list=18%, signal=20%
36SCHLOSSER_SERUM_RESPONSE_DN33-0.27-0.900.6650.8471.00055tags=15%, list=9%, signal=16%
37WONG_ADULT_TISSUE_STEM_MODULE30-0.28-0.900.3130.8321.00089tags=30%, list=14%, signal=33%
38STEIN_ESRRA_TARGETS19-0.27-0.890.3170.8191.000135tags=26%, list=22%, signal=33%
39MARTINEZ_RB1_TARGETS_DN25-0.28-0.890.3130.8131.00095tags=28%, list=15%, signal=32%
40MEBARKI_HCC_PROGENITOR_FZD8CRD_UP30-0.41-0.890.6540.8001.00091tags=43%, list=15%, signal=48%
41GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN17-0.35-0.880.3520.7951.000115tags=29%, list=19%, signal=35%
42WONG_EMBRYONIC_STEM_CELL_CORE22-0.32-0.860.6650.8051.00041tags=14%, list=7%, signal=14%
43REACTOME_MEMBRANE_TRAFFICKING27-0.20-0.850.6790.8181.000166tags=26%, list=27%, signal=34%
44GRESHOCK_CANCER_COPY_NUMBER_UP15-0.30-0.850.6690.8061.0002tags=7%, list=0%, signal=7%
45MEISSNER_NPC_HCP_WITH_H3K4ME216-0.44-0.840.6650.8051.00051tags=38%, list=8%, signal=40%
46NUYTTEN_NIPP1_TARGETS_DN28-0.19-0.830.6690.8011.00098tags=21%, list=16%, signal=24%
47BENPORATH_MYC_MAX_TARGETS34-0.31-0.820.6790.7991.00056tags=12%, list=9%, signal=12%
48MILI_PSEUDOPODIA_CHEMOTAXIS_DN22-0.23-0.810.3170.8011.00058tags=14%, list=9%, signal=15%
49RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP39-0.19-0.750.6790.8721.00038tags=8%, list=6%, signal=8%
50REACTOME_ADAPTIVE_IMMUNE_SYSTEM26-0.21-0.660.6540.9481.00044tags=8%, list=7%, signal=8%
51SHEN_SMARCA2_TARGETS_UP23-0.18-0.650.6790.9501.000201tags=39%, list=33%, signal=56%
52BROWNE_HCMV_INFECTION_4HR_DN15-0.29-0.610.6690.9541.0008tags=7%, list=1%, signal=7%
53KUMAR_TARGETS_OF_MLL_AF9_FUSION15-0.25-0.460.6690.9921.00080tags=20%, list=13%, signal=22%
Table: Gene sets enriched in phenotype Pro (2 samples) [plain text format]